Pharmacokinetic assessment of pyrazinamide and pyrazinoic acid in carbon tetrachloride-induced liver injury model in Wistar Rats

Pharmacokinetic assessment of pyrazinamide and pyrazinoic acid in carbon tetrachloride-induced liver injury model in Wistar Rats

Background: We investigated the pharmacokinetic behavior of pyrazinamide (PZA) and pyrazinoic acid (PA) in the presence of carbon-tetrachloride (CCl4) plus antitubercular treatment (ATT) drug-induced liver injury (DILI) in rats. Methods: Thirty rats utilized in the experiment were separated equally...

Full description

Bibliographic Details
Main Authors:	Swati Sharma, Vishal Sharma, Sunil Taneja, Alka Bhatia, Aishwarya Anand, Dibyajyoti Banerjee, Amol N Patil
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Journal of Pharmacy and Bioallied Sciences
Subjects:	carbon tetrachloride liver injury pharmacokinetics pharmacometabolomics pharmacometabonomics pyrazinamide pyrazines acid therapeutic drug monitoring
Online Access:	http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2023;volume=15;issue=3;spage=146;epage=151;aulast=Sharma

Similar Items

Pharmacokinetic assessment of isoniazid and acetylisoniazid in carbon tetrachloride-induced liver injury model in Wistar rats
by: Swati Sharma, et al.
Published: (2023-01-01)

Pharmacological evaluation of scopoletin in the carbon tetrachloride- Induced hepatotoxicity model in wistar rats
by: Swati Sharma, et al.
Published: (2022-01-01)

From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalised Medicine
by: Jeremy Everett
Published: (2016-09-01)

PYRAZINAMIDE/PYRAZINOIC ACID RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS: RECENT FINDINGS AND IMPLICATIONS FOR IMPROVING THE TREATMENT OF TUBERCULOSIS
by: R. M. Anthony, et al.
Published: (2018-12-01)

A novel inexpensive electrochemical sensor for pyrazinoic acid as a potential tool for the identification of pyrazinamide-resistant Mycobacterium tuberculosis
by: Daniel Rueda, et al.
Published: (2018-01-01)

The protective effect of naringenin against pyrazinamide-induced hepatotoxicity in male Wistar rats
by: Atef Abdel-Moneem Ali, et al.
Published: (2022-10-01)

Pyrazinamide-induced maculopapular rash
by: Khayyam Khalid, et al.
Published: (2010-01-01)

New insights into the mechanism of action of pyrazinamide, implications for susceptibility testing, and future regimens*
by: Richard M Anthony, et al.
Published: (2016-01-01)

Different spectrophotometric and TLC-densitometric methods for determination of pyrazinamide in presence of its impurity
by: Neven Magdy Habib, et al.
Published: (2017-06-01)

Pyrazinamide-induced phototoxicity: A case report and review of literature
by: Katiyar Subodh, et al.
Published: (2010-01-01)

Colorimetric methods for rapid determination of pyrazinamide resistance
by: Ahmet Ugur Akbal, et al.
Published: (2020-01-01)

Carbon tetrachloride
by: 8096 British Standards Institution

Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis
by: Mikaela Glader, et al.
Published: (2015-01-01)

Nigella sativa can Cure Hepatotoxicity Caused by Pyrazinamide Administration; A Lead from Animal Experiment
by: Amtul Hafeez, et al.
Published: (2020-12-01)

Efficient Synthesis of Pyrazinoic Acid Hybrid Conjugates
by: Siva S. Panda, et al.
Published: (2017-03-01)

Individualized Dosage of Tacrolimus for Renal Transplantation Patients Based on Pharmacometabonomics
by: Xiaoying He, et al.
Published: (2022-05-01)

In Situ Investigation of a Self-Accelerated Cocrystal Formation by Grinding Pyrazinamide with Oxalic Acid
by: Hannes Kulla, et al.
Published: (2016-07-01)

Clinical Significance of Preoperative Pyrazinamide-Containing Therapy in Tuberculous Constrictive Pericarditis
by: Fang L, et al.
Published: (2024-01-01)

Design, synthesis and biological activity of pyrazinamide derivatives for anti-Mycobacterium tuberculosis
by: Shiyang Zhou, et al.
Published: (2017-01-01)

Role of Nigella Sativa Seeds on Pyrazinamide Induced Hepatotoxicity
by: Amtul Hafeez , Akbar Waheed , Neelofar Yousaf
Published: (2019-03-01)

SIMULTANEOUS CONTENT ANALYSIS OF RIFAMPICIN, ISONIAZID, AND PYRAZINAMIDE IN TABLET DOSAGE FORM BY SPECTROPHOTOMETRY ULTRAVIOLET WITH DWM AND RSM
by: Muhammad Andry, et al.
Published: (2022-11-01)

DEVELOPMENT OF DERIVATIVE SPECTROPHOTOMETRIC METHOD FOR SIMULTANEOUS DETERMINATION OF PYRAZINAMIDE AND RIFAMPICIN IN CUBOSOME FORMULATION
by: Morgana Souza Marques, et al.
Published: (2021-06-01)

Genetic surveillance and outcomes of pyrazinamide and fluoroquinolones-resistant tuberculosis in Taiwan
by: Hsin-Ting Huang, et al.
Published: (2023-12-01)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in <it>Mycobacterium tuberculosis</it>
by: Parsons Linda M, et al.
Published: (2001-04-01)

Antimicrobial Activity of Pyrazinamide Coordination Frameworks Synthesized by Mechanochemistry
by: Sílvia Quaresma, et al.
Published: (2021-03-01)

Development of a population pharmacokinetic model of pyrazinamide to guide personalized therapy: impacts of geriatric and diabetes mellitus on clearance
by: Ryunha Kim, et al.
Published: (2023-05-01)

Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis
by: Shulan Dong, et al.
Published: (2024-01-01)

Assessment of adherence to antituberculosis drug regimen among patients receiving isoniazid, rifampin and pyrazinamide: Kerman, Iran
by: Seyyed Mojtaba Sohrevardi, et al.
Published: (2019-07-01)

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China
by: Hui Xia, et al.
Published: (2020-01-01)

A multiple genome analysis of Mycobacterium tuberculosis reveals specific novel genes and mutations associated with pyrazinamide resistance
by: Patricia Sheen, et al.
Published: (2017-10-01)

Performance of Wayne assay for detection of pyrazinamide resistance in Mycobacterium tuberculosis: a meta-analysis study
by: M.J. Nasiri, et al.
Published: (2021-07-01)

Aerosol products, sterilants, miscellaneous uses and carbon tetrachloride
Published: (1991)

Can crocin play a preventive role in Wistar rats with carbon tetrachloride-induced nephrotoxicity?
by: Mehmet Erdemli, et al.
Published: (2018-04-01)

Effect of Apitherapy Formulations against Carbon Tetrachloride-Induced Toxicity in Wistar Rats after Three Weeks of Treatment
by: Calin Vasile Andritoiu, et al.
Published: (2014-08-01)

Analysis of pncA gene expression in pyrazinamide-resistant and multidrug-resistant <i>Mycobacterium tuberculosis</i>
by: Wang Nan，, Yang Yu, Deng Ling, Wu Hui, Liu Zhihui, Meng Fanrong
Published: (2023-12-01)

Acetylcholinesterase enzyme inhibitor activity of some novel pyrazinamide condensed 1,2,3,4-tetrahydropyrimidines
by: Karthikeyan Elumalai, et al.
Published: (2015-03-01)

Pharmacokinetics in Pharmacometabolomics: Towards Personalized Medication
by: Jingai Jian, et al.
Published: (2023-11-01)

The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC–IM–MS Study
by: Billy Molloy, et al.
Published: (2021-06-01)

Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis
by: Manijeh Kahbazi, et al.
Published: (2018-04-01)

Resistance to pyrazinamide in Mycobacterium tuberculosis complex isolates from previously treated tuberculosis cases in Southwestern Oromia, Ethiopia
by: Getu Balay, et al.
Published: (2024-02-01)